GSGCX
Price
$45.87
Change
+$0.13 (+0.28%)
Updated
Jul 25 closing price
Net Assets
414.36M
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

GSGCX vs VIVIX

Header iconGSGCX vs VIVIX Comparison
Open Charts GSGCX vs VIVIXBanner chart's image
Goldman Sachs Equity Income C
Price$45.87
Change+$0.13 (+0.28%)
VolumeN/A
Net Assets414.36M
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
GSGCX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSGCX vs. VIVIX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGCX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. GSGCX (414M). VIVIX pays higher dividends than GSGCX: VIVIX (2.19) vs GSGCX (0.63). GSGCX was incepted earlier than VIVIX: GSGCX (28 years) vs VIVIX (27 years). GSGCX (1.95) is less costly to investors than VIVIX (0.04). GSGCX is a more actively managed with annual turnover of: 31.00 vs. VIVIX (9.00). GSGCX has a lower initial minimum investment than VIVIX: GSGCX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.30 vs. GSGCX (4.47). VIVIX return over 5 years is better than : 74.15 vs. GSGCX (38.17).
GSGCXVIVIXGSGCX / VIVIX
Total Expense Ratio1.750.044,375%
Annual Report Gross Expense Ratio1.950.044,875%
Fund Existence28 years27 years-
Gain YTD7.4566.290119%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets414M195B0%
Annual Yield % from dividends0.632.1929%
Returns for 1 year4.479.3048%
Returns for 3 years19.9133.7759%
Returns for 5 years38.1774.1551%
Returns for 10 years59.84115.3752%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLAY3.740.06
+1.63%
Relay Therapeutics
INCR1.550.01
+0.65%
Intercure Ltd
EXPD116.70-0.14
-0.12%
Expeditors International of Washington
XIFR9.52-0.07
-0.73%
XPLR Infrastructure LP
NLSP1.98-0.18
-8.33%
Nls Pharmaceutics Ltd